1,265 results on '"Salto–Tellez, Manuel"'
Search Results
102. Supplementary Table 4 from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
103. Data from Repression of NHE1 Expression by PPARγ Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo
104. Supplementary Methods from BRCA1 Deficiency Exacerbates Estrogen-Induced DNA Damage and Genomic Instability
105. Subcellular Epithelial HMGB1 Expression Is Associated with Colorectal Neoplastic Progression, Male Sex, Mismatch Repair Protein Expression, Lymph Node Positivity, and an ‘Immune Cold’ Phenotype Associated with Poor Survival
106. Abstract PD10-07: PD10-07 Low plasma estradiol, low expression of estrogen responsive genes and TP53 mutations are associated with poor anti-proliferative response to aromatase inhibitors
107. Abstract PD10-08: PD10-08 Immune cell infiltration associated with poor anti-proliferative response to aromatase inhibitors in postmenopausal women with primary ER-positive HER2-negative breast cancer
108. Abstract P2-03-08: Deconstructing the molecular characteristics of ER+ HER2+ early breast cancer in the POETIC trial using multiplex immunofluorescence and gene expression profiles
109. Clinical Trials and Digital Pathology—Toward Quantitative Therapeutic Immunohistochemistry and Tissue Hybridization
110. Technical note on the exploration of COVID-19 in autopsy material
111. Integrated molecular pathology: the Belfast model
112. HER2: An emerging biomarker in non-breast and non-gastric cancers
113. Analysis of wntless (WLS) expression in gastric, ovarian, and breast cancers reveals a strong association with HER2 overexpression
114. The impact of next generation sequencing technologies on haematological research – A review
115. Abstract A23: True-T – Improved prediction by holistic artificial intelligence-based quantification of T-cell response
116. Distinct molecular profiles of sporadic early onset colorectal cancer: a population-based cohort and systematic review
117. Digital pathology and image analysis in tissue biomarker research
118. Molecular pathology – The value of an integrative approach
119. Identification of a BRCA1-mRNA Splicing Complex Required for Efficient DNA Repair and Maintenance of Genomic Stability
120. More Than a Decade of Molecular Diagnostic Cytopathology Leading Diagnostic and Therapeutic Decision-Making
121. ICOSeg: Real-Time ICOS Protein Expression Segmentation from Immunohistochemistry Slides Using a Lightweight Conv-Transformer Network
122. Encrypted federated learning for secure decentralized collaboration in cancer image analysis
123. MicroRNA-34c Inversely Couples the Biological Functions of the Runt-related Transcription Factor RUNX2 and the Tumor Suppressor p53 in Osteosarcoma
124. Molecular mapping the presence of druggable targets in preinvasive and precursor breast lesions: A comprehensive review of biomarkers related to therapeutic interventions
125. BCL-2 system analysis identifies high-risk colorectal cancer patients
126. Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges
127. Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort Study
128. Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer
129. Digital slide viewing for primary reporting in gastrointestinal pathology: a validation study
130. Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma
131. General Roadmap and Core Steps for the Development of AI Tools in Digital Pathology
132. Biomarker identification and clinical validation
133. RE: Test of Four Colon Cancer Risk-Scores in Formalin Fixed Paraffin Embedded Microarray Gene Expression Data
134. Clinical and Testing Protocols for the Analysis of Epidermal Growth Factor Receptor Mutations in East Asian Patients with Non-small Cell Lung Cancer: A Combined Clinical-Molecular Pathological Approach
135. Loss of Runx3 Is a Key Event in Inducing Precancerous State of the Stomach
136. RUNX3 functions as an oncogene in ovarian cancer
137. Experienced versus inexperienced confocal endoscopists in the diagnosis of gastric adenocarcinoma and intestinal metaplasia on confocal images
138. Identification of a prognostic signature in colorectal cancer using combinatorial algorithm‐driven analysis
139. DEAD-box helicase DP103 defines metastatic potential of human breast cancers
140. Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program
141. p16 as a prognostic indicator in ovarian/tubal high-grade serous carcinoma
142. Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers
143. C/EBPα Is Up-regulated in a Subset of Hepatocellular Carcinomas and Plays a Role in Cell Growth and Proliferation
144. MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer
145. CD133 expression predicts for non-response to chemotherapy in colorectal cancer
146. Molecular-assisted immunohistochemical optimization
147. Claudin-1 Has Tumor Suppressive Activity and Is a Direct Target of RUNX3 in Gastric Epithelial Cells
148. Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer
149. Swarm learning for decentralized artificial intelligence in cancer histopathology
150. Orthogonal MET analysis in a population‐representative stage II–III colon cancer cohort: prognostic and potential therapeutic implications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.